HYVET
This trial evaluated the safety and benefits of prescribing blood pressure medication to people over the age of 80.
Impact of clinical trials: high blood and vascular disease
BHF-funded trials have helped shape clinical guidelines for high blood pressure and advance treatment of vascular disease.
High blood pressure trials
PATHWAY 1,2 and 3
These studies have led to more personalised ways to treat high blood pressure. Their results have helped shape care guidelines around the world.
TIME
The TIME trial tested whether blood pressure lowering medication is more effective when taken in the morning or at night time.
Vascular disease trials
AIMS
AIMS tested whether a blood pressure lowering drug could help treat people with Marfan syndrome. This inherited condition affects connective tissue.
Nordic pole walking
Researchers assessed whether a walking programme using special walking poles could help people with peripheral arterial disease.
ACST-2
BHF supported an international trial comparing surgery or stenting for carotid artery disease - a condition where the large blood vessels that supply oxygen to the brain become narrowed.